Heart Failure Clinical Trial

Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring

Summary

A study evaluating the impact of remotely collected data, measured using digital technologies, on the use of guideline-recommended heart failure therapy in adult participants with heart failure.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

History of chronic heart failure.
Ejection fraction equal to or below 40%.
New York Heart Association (NYHA) class II to class III.
Enrollment during or within 30 days after a hospitalization, emergency department, or urgent, unscheduled clinic/office visit with primary diagnosis of heart failure.

Exclusion Criteria:

Has received a major organ transplant (e.g., lung, liver, heart, bone marrow, kidney).
Currently in an investigational device or drug study.
Unwilling or unable to wear a digital wrist watch device for measuring blood pressure and other parameters during waking hours.

Study is for people with:

Heart Failure

Estimated Enrollment:

18

Study ID:

NCT04292275

Recruitment Status:

Terminated

Sponsor:

Amgen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Yale New Haven Hospital
New Haven Connecticut, 06520, United States
Cardiology Associates of Fairfield County, PC
Stamford Connecticut, 06905, United States
MercyOne Northeast Iowa Family Medicine and Residency
Waterloo Iowa, 50702, United States
Virtua Health Inc.
Voorhees New Jersey, 08043, United States
Duke University Medical Center
Durham North Carolina, 27710, United States
Diagnostic Cardiology Group
Chattanooga Tennessee, 37404, United States
Tennessee Center for Clinical Trials, a division of Cardiology and Vascular Associates PLLC
Tullahoma Tennessee, 37388, United States
Inova Heart and Vascular Institute
Falls Church Virginia, 22042, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

18

Study ID:

NCT04292275

Recruitment Status:

Terminated

Sponsor:


Amgen

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.